We are live on ! Find out more
HIM

Hotaling Investment Management Portfolio holdings

AUM $221M
1-Year Est. Return 12.77%
This Fund
S&P 500
This Quarter Est. Return
-13.27%
1 Year Est. Return
-12.77%
3 Year Est. Return
+52.6%
5 Year Est. Return
10 Year Est. Return
AUM
$230M
AUM Growth
-$29.9M
Cap. Flow
+$8.69M
Cap. Flow %
3.78%
Top 10 Hldgs %
37.17%
Holding
134
New
7
Increased
89
Reduced
21
Closed
13

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$2.55M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.67M
3
PFE icon
Pfizer
PFE
+$1.54M
4
MRK icon
Merck
MRK
+$1.45M
5
DE icon
Deere & Co
DE
+$906K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.11M
2
IDXX icon
Idexx Laboratories
IDXX
+$1.85M
3
F icon
Ford
F
+$1.65M
4
TER icon
Teradyne
TER
+$1.35M
5
TPR icon
Tapestry
TPR
+$1.06M

Sector Composition

Rank Sector Weight
1 Technology 20.5%
2 Healthcare 20.21%
3 Financials 12.59%
4 Consumer Discretionary 9.79%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDXX icon
126
Idexx Laboratories
IDXX
$46.2B
-3,384
Closed -$1.85M
IWB icon
127
iShares Russell 1000 ETF
IWB
$50B
-837
Closed -$209K
JNPR
128
DELISTED
Juniper Networks
JNPR
-6,374
Closed -$237K
NQP
129
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
-11,903
Closed -$161K
NVDA icon
130
NVIDIA
NVDA
$5.27T
-114,000
Closed -$3.11M
TER icon
131
Teradyne
TER
$59.3B
-11,436
Closed -$1.35M
TPR icon
132
Tapestry
TPR
$32.4B
-28,559
Closed -$1.06M
XYL icon
133
Xylem
XYL
$28.8B
-2,645
Closed -$226K
SBNY
134
DELISTED
Signature Bank
SBNY
-766
Closed -$225K

Similar funds

Hotaling Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Hotaling Investment Management held 134 positions worth $230M, down 12% from $260M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Hotaling Investment Management deployed $8.69M of net new capital in Q2 2022, opening 7 new positions and adding to 89 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 6,222 shares worth $1.75M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $101K trimmed.

  • Hotaling Investment Management's largest Q2 2022 buy was Vertex Pharmaceuticals: 6,222 shares worth $1.75M.
  • Hotaling Investment Management added most to Johnson & Johnson in Q2 2022, an estimated $2.55M increase.
  • Hotaling Investment Management's biggest Q2 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $101K.
  • Hotaling Investment Management fully exited NVIDIA in Q2 2022, selling an estimated $3.11M.
  • Hotaling Investment Management's ten largest holdings make up 37% of its $230M portfolio in Q2 2022.
  • Hotaling Investment Management opened 7 new positions and closed 13 in Q2 2022.
  • Hotaling Investment Management's portfolio value fell 12% quarter-over-quarter to $230M.

Based on Hotaling Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.